Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Benzimidazole
1.2.3 Pyrantel
1.2.4 Piperazine Citrate
1.2.5 Others
1.3 Market by Application
1.3.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Helminthic Infestations Therapeutics Market Perspective (2017-2028)
2.2 Helminthic Infestations Therapeutics Growth Trends by Region
2.2.1 Helminthic Infestations Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Helminthic Infestations Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Helminthic Infestations Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Helminthic Infestations Therapeutics Market Dynamics
2.3.1 Helminthic Infestations Therapeutics Industry Trends
2.3.2 Helminthic Infestations Therapeutics Market Drivers
2.3.3 Helminthic Infestations Therapeutics Market Challenges
2.3.4 Helminthic Infestations Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helminthic Infestations Therapeutics Players by Revenue
3.1.1 Global Top Helminthic Infestations Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Helminthic Infestations Therapeutics Revenue
3.4 Global Helminthic Infestations Therapeutics Market Concentration Ratio
3.4.1 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2021
3.5 Helminthic Infestations Therapeutics Key Players Head office and Area Served
3.6 Key Players Helminthic Infestations Therapeutics Product Solution and Service
3.7 Date of Enter into Helminthic Infestations Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Helminthic Infestations Therapeutics Breakdown Data by Type
4.1 Global Helminthic Infestations Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2023-2028)
5 Helminthic Infestations Therapeutics Breakdown Data by Application
5.1 Global Helminthic Infestations Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Helminthic Infestations Therapeutics Market Size (2017-2028)
6.2 North America Helminthic Infestations Therapeutics Market Size by Type
6.2.1 North America Helminthic Infestations Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Helminthic Infestations Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Helminthic Infestations Therapeutics Market Share by Type (2017-2028)
6.3 North America Helminthic Infestations Therapeutics Market Size by Application
6.3.1 North America Helminthic Infestations Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Helminthic Infestations Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Helminthic Infestations Therapeutics Market Share by Application (2017-2028)
6.4 North America Helminthic Infestations Therapeutics Market Size by Country
6.4.1 North America Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Helminthic Infestations Therapeutics Market Size (2017-2028)
7.2 Europe Helminthic Infestations Therapeutics Market Size by Type
7.2.1 Europe Helminthic Infestations Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Helminthic Infestations Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Helminthic Infestations Therapeutics Market Share by Type (2017-2028)
7.3 Europe Helminthic Infestations Therapeutics Market Size by Application
7.3.1 Europe Helminthic Infestations Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Helminthic Infestations Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Helminthic Infestations Therapeutics Market Share by Application (2017-2028)
7.4 Europe Helminthic Infestations Therapeutics Market Size by Country
7.4.1 Europe Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type
8.2.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Helminthic Infestations Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application
8.3.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Helminthic Infestations Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region
8.4.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Helminthic Infestations Therapeutics Market Size (2017-2028)
9.2 Latin America Helminthic Infestations Therapeutics Market Size by Type
9.2.1 Latin America Helminthic Infestations Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Helminthic Infestations Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Helminthic Infestations Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Helminthic Infestations Therapeutics Market Size by Application
9.3.1 Latin America Helminthic Infestations Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Helminthic Infestations Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Helminthic Infestations Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Helminthic Infestations Therapeutics Market Size by Country
9.4.1 Latin America Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type
10.2.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Helminthic Infestations Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application
10.3.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Helminthic Infestations Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country
10.4.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Neural Analytics, Inc.
11.1.1 Neural Analytics, Inc. Company Details
11.1.2 Neural Analytics, Inc. Business Overview
11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Introduction
11.1.4 Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.1.5 Neural Analytics, Inc. Recent Developments
11.2 M3 Biotechnology, Inc.
11.2.1 M3 Biotechnology, Inc. Company Details
11.2.2 M3 Biotechnology, Inc. Business Overview
11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Introduction
11.2.4 M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.2.5 M3 Biotechnology, Inc. Recent Developments
11.3 Cerevance
11.3.1 Cerevance Company Details
11.3.2 Cerevance Business Overview
11.3.3 Cerevance Helminthic Infestations Therapeutics Introduction
11.3.4 Cerevance Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.3.5 Cerevance Recent Developments
11.4 Mitochon Pharmaceuticals, Inc.
11.4.1 Mitochon Pharmaceuticals, Inc. Company Details
11.4.2 Mitochon Pharmaceuticals, Inc. Business Overview
11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Introduction
11.4.4 Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.4.5 Mitochon Pharmaceuticals, Inc. Recent Developments
11.5 Peptilogics
11.5.1 Peptilogics Company Details
11.5.2 Peptilogics Business Overview
11.5.3 Peptilogics Helminthic Infestations Therapeutics Introduction
11.5.4 Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.5.5 Peptilogics Recent Developments
11.6 Farmoquimica S/A
11.6.1 Farmoquimica S/A Company Details
11.6.2 Farmoquimica S/A Business Overview
11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Introduction
11.6.4 Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.6.5 Farmoquimica S/A Recent Developments
11.7 biOasis Technologies, Inc.
11.7.1 biOasis Technologies, Inc. Company Details
11.7.2 biOasis Technologies, Inc. Business Overview
11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Introduction
11.7.4 biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.7.5 biOasis Technologies, Inc. Recent Developments
11.8 HCA Healthcare, Inc.
11.8.1 HCA Healthcare, Inc. Company Details
11.8.2 HCA Healthcare, Inc. Business Overview
11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Introduction
11.8.4 HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.8.5 HCA Healthcare, Inc. Recent Developments
11.9 Alzeca Biosciences, Inc.
11.9.1 Alzeca Biosciences, Inc. Company Details
11.9.2 Alzeca Biosciences, Inc. Business Overview
11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Introduction
11.9.4 Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.9.5 Alzeca Biosciences, Inc. Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.10.5 Johnson & Johnson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer